Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudine-resistant hepatitis B virus (HBV) infection.

• 阿得福韦是最近被批准用于治疗野生型和拉米夫定抵抗型乙型肝炎病毒感染的一种新药。